Biopharm et al, take another look at the posters/abstracts/slides/presentations that either Dr. NK or Dr. TK(Precision for Medicine, a subsidiary of Perkin-Elmer) presented as co-authors at SITC or AACR a few years back. CJG may have them archived.
I recall posting here about an occasion that I attended/saw when a lady Ph.D. from Merck received a 15’ explanation from Dr. NK of the results shown on a particular poster at SITC or AACR. That poster dealt with the many immunotherapy targets that had been isolated from the failed Phase-3 trial of PPHM. I have always harbored the thought that MRK would become a clinical trial sponsor, in which Bavi would be involved, as a result of that dialogue between reps from MRK and PPHM.
Conspicuous by its absence was a discussion of the particular big 10 BP mentioned in yesterday’s conference call. I did not hear Bavi mentioned at all, or its role in filling Franklin, or its potential role in filling or partly filling the Milford reactors in the future.
News 
Market Data 
Discover 
